Expression of interleukin‐17 in primary Sjögren's syndrome and the correlation with disease severity: A systematic review and meta‐analysis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Scandinavian Journal of Immunology

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/sji.12649PMID 29476557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin‐17 and ‐22 synergy linking inflammation and EMT‐dependent fibrosis in Sjögren’s syndrome

  2019cited by this paper
• STAT4, TRAF3IP2, IL10, and HCP5 Polymorphisms in Sjögren's Syndrome: Association with Disease Susceptibility and Clinical Aspects

  2019cited by this paper
• Role of tear film biomarkers in the diagnosis and management of dry eye disease

  2019cited by this paper
• Targeting interleukin-17 in chronic inflammatory disease: A clinical perspective

  2019cited by this paper
• Quantifying publication bias in meta‐analysis

  2018cited by this paper
• Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease

  2017cited by this paper
• Is there a role for IL-17 in the pathogenesis of systemic sclerosis?

  2017cited by this paper
• Cytokines as therapeutic targets in primary Sjögren syndrome

  2017cited by this paper
• Present and future of biologic drugs in primary Sjögren’s syndrome

  2017cited by this paper
• Cutaneous and Mucosal Manifestations of Sjögren’s Syndrome

  2017cited by this paper
• The prognostic value of interleukin-17 in lung cancer: A systematic review with meta-analysis based on Chinese patients

  2017cited by this paper
• Young adult survivors of childhood acute lymphoblastic leukemia show evidence of chronic inflammation and cellular aging

  2017cited by this paper
• Insight into pathogenesis of Sjögren's syndrome: Dissection on autoimmune infiltrates and epithelial cells.

  2017cited by this paper
• Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome

  2017cited by this paper
• T Cell Polarization toward TH2/TFH2 and TH17/TFH17 in Patients with IgG4-Related Disease

  2017cited by this paper
• Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome

  2017cited by this paper
• Sjögren’s syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from Short Form 36 questionnaire and a meta-analysis

  2017cited by this paper
• Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment

  2017cited by this paper
• 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts

  2017cited by this paper
• What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome?

  2017cited by this paper
• Autoantibodies, detection methods and panels for diagnosis of Sjögren's syndrome.

  2017cited by this paper
• B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome

  2017cited by this paper
• The value of rituximab treatment in primary Sjögren's syndrome.

  2017cited by this paper
• Treatment Guidelines for Rheumatologic Manifestations of Sjögren's Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain

  2017cited by this paper
• [Change of Plasma Interleukin-17 Level in Patients with Extranodal NK/T-Cell Lymphoma and Its Clinical Significance].

  2017cited by this paper
• New Treatment Guidelines for Sjögren's Disease.

  2016cited by this paper
• Sjögren syndrome

  2016cited by this paper
• 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome

  2016cited by this paper
• A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren’s syndrome

  2016cited by this paper
• Predicting the risk for lymphoma development in Sjogren syndrome

  2016cited by this paper
• Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome

  2016cited by this paper
• Potential involvement of IL-22 and IL-22-producing cells in the infl amed salivary glands of patients with Sjögren’s syndrome

  2016cited by this paper
• Association of BAFF and IL‐17A with subphenotypes of primary Sjögren's syndrome

  2016cited by this paper
• Saliva as a potential tool for diagnosis of dry mouth including Sjögren's syndrome.

  2015cited by this paper
• Rate, risk factors and causes of mortality in patients with Sjögren's syndrome: a systematic review and meta-analysis of cohort studies.

  2015cited by this paper
• Cyclosporine A Suppresses the Activation of the Th17 Cells in Patients with Primary Sjögren's Syndrome.

  2015cited by this paper
• Determination of serum interleukin-17 and significance in patients with primary Sjgren's syndrome

  2014cited by this paper
• The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses

  2014cited by this paper
• Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome.

  2014cited by this paper
• Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren’s syndrome

  2014cited by this paper
• Mitigated Tregs and Augmented Th17 Cells and Cytokines are Associated with Severity of Experimental Autoimmune Neuritis

  2014cited by this paper
• Differential Cytokine Expression and Regulatory Cells in Patients with Primary and Secondary Sjögren's Syndrome

  2014cited by this paper
• Expression of Th17 related cytokines on ocular surface of dry eye and its significance

  2014cited by this paper
• Anaplastic large cell lymphoma with paraneoplastic neutrophilia: an association between IL-17 elevation and aggressive disease progression

  2014cited by this paper
• IL-17 induces radiation resistance of B lymphoma cells by suppressing p53 expression and thereby inhibiting irradiation-triggered apoptosis

  2014cited by this paper
• Analysis of Th17-associated cytokines in tears of patients with dry eye syndrome

  2014cited by this paper
• Th17 cells play a critical role in the development of experimental Sjögren's syndrome

  2014cited by this paper
• Identification of lymphoma predictors in patients with primary Sjögren’s syndrome: a systematic literature review and meta-analysis

  2014cited by this paper
• Increased levels of serum galectin-3 in patients with primary Sjögren's syndrome: associated with interstitial lung disease.

  2014cited by this paper
• IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes.

  2014cited by this paper
• CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement.

  2014cited by this paper
• Unmasking the pathogenic role of IL-17 axis in primary Sjögren's syndrome: a new era for therapeutic targeting?

  2014cited by this paper
• B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren’s syndrome: the similarities and differences

  2014cited by this paper
• Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.

  2013cited by this paper
• Genetic associations to germinal centre formation in primary Sjögren's syndrome

  2013cited by this paper
• Expression of interleukin-17 and interleukin-22 in supernatant of peripheral blood mononuclear cell and tear in dry eye patient

  2013cited by this paper
• Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics.

  2013cited by this paper
• Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjögren's syndrome

  2013cited by this paper
• A link between interferon and augmented plasmin generation in exocrine gland damage in Sjögren's syndrome.

  2013cited by this paper
• Activity of T-helper cells in patients with primary Sjogren's syndrome.

  2013cited by this paper
• IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14(bright)CD16+ monocytes.

  2013cited by this paper
• IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren's syndrome.

  2013cited by this paper
• Corneal nerve structure and function in patients with non-sjogren dry eye: clinical correlations.

  2013cited by this paper
• Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease

  2012cited by this paper
• Anti-Natalizumab Antibodies in Patients with Multiple Sclerosis

  2012cited by this paper
• Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sjögren's syndrome

  2012cited by this paper
• Expression of IL-17, IL-23 and Their Receptors in Minor Salivary Glands of Patients with Primary Sjögren's Syndrome

  2012cited by this paper
• Selective localization of T helper subsets in labial salivary glands from primary Sjögren's syndrome patients

  2012cited by this paper
• Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome

  2012cited by this paper
• TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome

  2012cited by this paper
• IL-17-producing CD4−CD8− T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjögren's syndrome

  2012cited by this paper
• Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease.

  2012cited by this paper
• Investigating the Relationship between Serum Interleukin-17 Levels and Systemic Immune-Mediated Disease in Patients with Dry Eye Syndrome

  2011cited by this paper
• Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.

  2011cited by this paper
• Disturbance of cytokine networks in Sjögren's syndrome

  2011cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias.

  2011cited by this paper
• Interleukin-17 in Various Ocular Surface Inflammatory Diseases

  2010cited by this paper
• The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren's syndrome.

  2010cited by this paper
• Immunopathology and Infectious Diseases Systemic and Local Interleukin-17 and Linked Cytokines Associated with Sjögren ’ s Syndrome Immunopathogenesis

  2010cited by this paper
• Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis.

  2009cited by this paper
• Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome.

  2009cited by this paper
• Anti‐CD20 treatment in Primary Sjögren’s Syndrome

  2008cited by this paper
• An overview of IL-17 function and signaling.

  2008cited by this paper
• Bmc Medical Research Methodology Open Access Using Reflexivity to Enhance In-depth Interviewing Skills for the Clinician Researcher

  2008cited by this paper
• Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.

  2008cited by this paper
• Identification of IL-18 and Th17 Cells in Salivary Glands of Patients with Sjögren’s Syndrome, and Amplification of IL-17-Mediated Secretion of Inflammatory Cytokines from Salivary Gland Cells by IL-181

  2008cited by this paper
• Lack of efficacy of etanercept in Sjögren syndrome correlates with failed suppression of tumour necrosis factor α and systemic immune activation

  2008cited by this paper
• Interpretation of tests of heterogeneity and bias in meta-analysis.

  2008cited by this paper
• Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF.

  2005cited by this paper
• Estimating the mean and variance from the median, range, and the size of a sample

  2005cited by this paper
• Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

  2002cited by this paper
• The histopathology of Sjögren's syndrome in labial salivary gland biopsies.

  1974cited by this paper
• Clinical Immunology

  1972cited by this paper

• High activity of human cytomegalovirus in patients with Sjögren's disease.

  2025cites this paper
• Varenicline Solution Nasal Spray for the Treatment of Dry Eye Disease in Sjogren’s Disease: A Pilot Study

  2025cites this paper
• Expression of interleukin-18 in primary Sjögren syndrome and its potential mechanisms with disease: A systematic review and meta-analysis

  2025cites this paper
• The role of microRNAs in primary Sjögren’s disease: deciphering regulatory networks and assessing current therapeutic perspectives

  2025cites this paper
• Sjogren’s Disease and Elevated Cardiovascular Risk: Mechanisms and Treatment

  2025cites this paper
• The Conjunctival Microbiome and Dry Eye: What We Know and Controversies

  2024cites this paper
• Evaluation of ocular surface inflammation and systemic conditions in patients with systemic lupus erythematosus: a cross-sectional study

  2024cites this paper
• Sjögren's Syndrome and Ankylosing Spondylitis Association: A Case-Based Review.

  2024cites this paper
• Immune and non-immune mediators in the fibrosis pathogenesis of salivary gland in Sjögren’s syndrome

  2024cites this paper
• Interpreting the Function of the IL-23/IL-17 Axis through Bioinformatics.

  2024cites this paper
• Efficacy of RCI001 as a Therapeutic Candidate in a Primary Sjögren Syndrome Mouse Model

  2024cites this paper
• Inflammatory cytokines and their potential role in Sjogren’s syndrome risk: insights from a mendelian randomization study

  2024cites this paper
• Relationship between Chinese Herbal Medicine Use and Risk of Sjögren’s Syndrome in Patients with Rheumatoid Arthritis: A Retrospective, Population-Based, Nested Case-Control Study

  2023cites this paper
• Updates in diagnostics, treatments, and correlations between oral and ocular manifestations of Sjogren's syndrome.

  2022cites this paper
• Levels of IL-23/IL-17 Axis in Plasma and Gingival Tissue of Periodontitis Patients According to the New Classification

  2022cites this paper
• Potential Mechanisms of White Peony against Primary Sjögren's Syndrome Based on Network Pharmacology and Molecular Docking

  2022cites this paper
• Early Dry Eye Disease Onset in a NOD.H-2h4 Mouse Model of Sjögren's Syndrome

  2022cites this paper
• Long-Term Post-COVID-19 Associated Oral Inflammatory Sequelae

  2022cites this paper
• Diurnal variation on tear stability and correlation with tear cytokine concentration.

  2022cites this paper
• The role of Th9 CD4 + T cells and IL‐9 during primary Sjogren's syndrome

  2022cites this paper
• Mechanisms of Secretory Dysfunction in Autoimmune Sjögren’s Syndrome

  2021cites this paper
• New frontiers in precision medicine for Sjogren’s syndrome

  2021cites this paper
• Sex Differences in Otolaryngology: Focus on the Emerging Role of Estrogens in Inflammatory and Pro-Resolving Responses

  2021cites this paper
• Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells

  2021cites this paper
• Primary Sjogren Syndrome: Focus on Innate Immune Cells and Inflammation

  2020cites this paper
• A prospective cross-sectional study of serum IL-17A in antisynthetase syndrome

  2020cites this paper
• T Cells Subsets in the Immunopathology and Treatment of Sjogren’s Syndrome

  2020cites this paper
• Immunohistochemical detection of IL-17 and IL-23 improves the identification of patients with a possible diagnosis of Sjogren's syndrome.

  2020cites this paper
• Significance of anti-Ro/SSA antibodies in the response and retention of abatacept in patients with rheumatoid arthritis: a multicentre cohort study

  2020cites this paper
• Proportion of T follicular helper cells in peripheral blood of rheumatoid arthritis patients: a systematic review and meta-analysis

  2020cites this paper
• Lung complications of Sjogren syndrome

  2020cites this paper
• Axial Articular Manifestations in Primary Sjögren Syndrome: Association With Spondyloarthritis

  2020cites this paper
• The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials.

  2019cites this paper
• Salivary gland immunization via Wharton's duct activates differential T‐cell responses within the salivary gland immune system

  2019cites this paper
• MiR-let-7d-3p regulates IL-17 expression through targeting AKT1/mTOR signaling in CD4+ T cells

  2019cites this paper
• Targeting interleukin-17 in chronic inflammatory disease: A clinical perspective

  2019cites this paper
• Role of tear film biomarkers in the diagnosis and management of dry eye disease

  2019cites this paper
• Emerging drugs for primary Sjögren’s syndrome

  2019cites this paper
• Interleukin‐17 and ‐22 synergy linking inflammation and EMT‐dependent fibrosis in Sjögren’s syndrome

  2019cites this paper
• STAT4, TRAF3IP2, IL10, and HCP5 Polymorphisms in Sjögren's Syndrome: Association with Disease Susceptibility and Clinical Aspects

  2019cites this paper
• Role of Salivary Immune Parameters in Patients With Primary Sjögren's Syndrome

  2018cites this paper
• Oral Disorders in Sjögren’s Syndrome

  2018cites this paper
• Level of tear cytokines in population‐level participants and correlation with clinical features

  2018cites this paper